Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Quindós G[au]:

Epidemiology of candidaemia and invasive candidiasis. A changing face. Quindós G et al. Rev Iberoam Micol. (2014)

[Statement in favor of the foundation of the Iberoamerican Society for Medical Mycology]. Quindós G et al. Rev Iberoam Micol. (2017)

[Invasive infection diseases by filamentous fungi]. Pemán J et al. Rev Iberoam Micol. (2014)

Search results

Items: 1 to 50 of 215

1.

Corrigendum: Antifungal Activity of the Human Uterine Cervical Stem Cells Conditioned Medium (hUCESC-CM) Against Candida albicans and Other Medically Relevant Species of Candida.

Schneider J, Mateo E, Marcos-Arias C, Eiró N, Vizoso F, Pérez-Fernández R, Eraso E, Quindós G.

Front Microbiol. 2019 Jun 11;10:1297. doi: 10.3389/fmicb.2019.01297. eCollection 2019.

2.

Effect of biomaterials hydrophobicity and roughness on biofilm development.

De-la-Pinta I, Cobos M, Ibarretxe J, Montoya E, Eraso E, Guraya T, Quindós G.

J Mater Sci Mater Med. 2019 Jun 19;30(7):77. doi: 10.1007/s10856-019-6281-3.

PMID:
31218489
3.
4.

Killing kinetics of anidulafungin, caspofungin and micafungin against Candida parapsilosis species complex: Evaluation of the fungicidal activity.

Gil-Alonso S, Quindós G, Cantón E, Eraso E, Jauregizar N.

Rev Iberoam Micol. 2019 Jan - Mar;36(1):24-29. doi: 10.1016/j.riam.2018.12.001. Epub 2019 Mar 2.

PMID:
30837186
5.

Therapeutic tools for oral candidiasis: Current and new antifungal drugs.

Quindós G, Gil-Alonso S, Marcos-Arias C, Sevillano E, Mateo E, Jauregizar N, Eraso E.

Med Oral Patol Oral Cir Bucal. 2019 Mar 1;24(2):e172-e180. doi: 10.4317/medoral.22978.

6.

The continuous changes in the aetiology and epidemiology of invasive candidiasis: from familiar Candida albicans to multiresistant Candida auris.

Quindós G, Marcos-Arias C, San-Millán R, Mateo E, Eraso E.

Int Microbiol. 2018 Sep;21(3):107-119. doi: 10.1007/s10123-018-0014-1. Epub 2018 Jul 6. Review.

PMID:
30810955
7.

Antifungal Activity of the Human Uterine Cervical Stem Cells Conditioned Medium (hUCESC-CM) Against Candida albicans and Other Medically Relevant Species of Candida.

Schneider J, Mateo E, Marcos-Arias C, Eiró N, Vizoso F, Pérez-Fernández R, Eraso E, Quindós G.

Front Microbiol. 2018 Nov 21;9:2818. doi: 10.3389/fmicb.2018.02818. eCollection 2018. Erratum in: Front Microbiol. 2019 Jun 11;10:1297.

8.

[Epidemiology of invasive mycoses: A landscape in continuous change].

Quindós G.

Rev Iberoam Micol. 2018 Oct - Dec;35(4):171-178. doi: 10.1016/j.riam.2018.07.002. Epub 2018 Nov 19. Review. Spanish.

PMID:
30466999
9.

Method-Dependent Epidemiological Cutoff Values for Detection of Triazole Resistance in Candida and Aspergillus Species for the Sensititre YeastOne Colorimetric Broth and Etest Agar Diffusion Methods.

Espinel-Ingroff A, Turnidge J, Alastruey-Izquierdo A, Botterel F, Canton E, Castro C, Chen YC, Chen Y, Chryssanthou E, Dannaoui E, Garcia-Effron G, Gonzalez GM, Govender NP, Guinea J, Kidd S, Lackner M, Lass-Flörl C, Linares-Sicilia MJ, López-Soria L, Magobo R, Pelaez T, Quindós G, Rodriguez-Iglesia MA, Ruiz MA, Sánchez-Reus F, Sanguinetti M, Shields R, Szweda P, Tortorano A, Wengenack NL, Bramati S, Cavanna C, DeLuca C, Gelmi M, Grancini A, Lombardi G, Meletiadis J, Negri CE, Passera M, Peman J, Prigitano A, Sala E, Tejada M.

Antimicrob Agents Chemother. 2018 Dec 21;63(1). pii: e01651-18. doi: 10.1128/AAC.01651-18. Print 2019 Jan.

10.

Design and validation of a multiplex PCR protocol for microsatellite typing of Candida parapsilosis sensu stricto isolates.

Trobajo-Sanmartín C, Ezpeleta G, Pais C, Eraso E, Quindós G.

BMC Genomics. 2018 Sep 29;19(1):718. doi: 10.1186/s12864-018-5065-3.

11.

Prevalence and antifungal susceptibility profiles of Candida glabrata, Candida parapsilosis and their close-related species in oral candidiasis.

Miranda-Cadena K, Marcos-Arias C, Mateo E, Aguirre JM, Quindós G, Eraso E.

Arch Oral Biol. 2018 Nov;95:100-107. doi: 10.1016/j.archoralbio.2018.07.017. Epub 2018 Jul 31.

PMID:
30096698
12.

Oral Candida colonization in patients with chronic periodontitis. Is there any relationship?

De-La-Torre J, Quindós G, Marcos-Arias C, Marichalar-Mendia X, Gainza ML, Eraso E, Acha-Sagredo A, Aguirre-Urizar JM.

Rev Iberoam Micol. 2018 Jul - Sep;35(3):134-139. doi: 10.1016/j.riam.2018.03.005. Epub 2018 Aug 3.

PMID:
30082174
13.

Developing collaborative works for faster progress on fungal respiratory infections in cystic fibrosis.

Schwarz C, Vandeputte P, Rougeron A, Giraud S, Dugé de Bernonville T, Duvaux L, Gastebois A, Alastruey-Izquierdo A, Martín-Gomez MT, Mazuelos EM, Sole A, Cano J, Pemán J, Quindos G, Botterel F, Bougnoux ME, Chen S, Delhaès L, Favennec L, Ranque S, Sedlacek L, Steinmann J, Vazquez J, Williams C, Meyer W, Le Gal S, Nevez G, Fleury M, Papon N, Symoens F, Bouchara JP; ECMM/ISHAM working group Fungal respiratory infections in Cystic Fibrosis (Fri-CF).

Med Mycol. 2018 Apr 1;56(suppl_1):42-59. doi: 10.1093/mmy/myx106. Review.

PMID:
29538733
14.

[Statement in favor of the foundation of the Iberoamerican Society for Medical Mycology].

Quindós G, Pemán J.

Rev Iberoam Micol. 2017 Oct - Dec;34(4):189-191. doi: 10.1016/j.riam.2017.09.003. Spanish. No abstract available.

PMID:
29132742
15.

EPICO 4.0. 'Total quality' in the management of invasive candidiasis in critically ill patients by analysing the integrated process.

Zaragoza R, Ferrer R, Llinares P, Maseda E, Rodríguez A, Grau S, Quindós G; EPICO Project Group.

Rev Iberoam Micol. 2017 Jul - Sep;34(3):143-157. doi: 10.1016/j.riam.2017.03.008. Epub 2017 Jul 19.

PMID:
28734773
16.

Phytochemical composition, anti-biofilm and anti-quorum sensing potential of fruit, stem and leaves of Salvadora persica L. methanolic extracts.

Noumi E, Snoussi M, Merghni A, Nazzaro F, Quindós G, Akdamar G, Mastouri M, Al-Sieni A, Ceylan O.

Microb Pathog. 2017 Aug;109:169-176. doi: 10.1016/j.micpath.2017.05.036. Epub 2017 May 26.

PMID:
28552808
17.

Usefulness of the Non-conventional Caenorhabditis elegans Model to Assess Candida Virulence.

Ortega-Riveros M, De-la-Pinta I, Marcos-Arias C, Ezpeleta G, Quindós G, Eraso E.

Mycopathologia. 2017 Oct;182(9-10):785-795. doi: 10.1007/s11046-017-0142-8. Epub 2017 May 18.

PMID:
28523422
18.

Erratum to: "EPICO 3.0. Management of non-neutropenic patients in medical wards" [Rev Iberoam Micol. 33 (4) (2016) 216-223].

Ferrer R, Zaragoza R, Rodríguez AH, Maseda E, Llinares P, Grau S, Álvarez-Lerma F, Quindós G, Salavert M, Huarte R; EPICO Project Group.

Rev Iberoam Micol. 2017 Jan - Mar;34(1):63. doi: 10.1016/j.riam.2017.02.004. No abstract available.

PMID:
28249673
19.

In Vitro Antifungal Susceptibility of Oral Candida Isolates from Patients Suffering from Caries and Chronic Periodontitis.

De-la-Torre J, Ortiz-Samperio ME, Marcos-Arias C, Marichalar-Mendia X, Eraso E, Echebarria-Goicouria MÁ, Aguirre-Urizar JM, Quindós G.

Mycopathologia. 2017 Jun;182(5-6):471-485. doi: 10.1007/s11046-017-0112-1. Epub 2017 Jan 25.

PMID:
28124220
20.

Twitter as a Tool for Teaching and Communicating Microbiology: The #microMOOCSEM Initiative.

López-Goñi I, Martínez-Viñas MJ, Antón J, Cid VJ, González AM, Brown-Jaque M, García-Lobo JM, Sánchez M, Vilchez JI, Robledo-Mahón T, Seder-Colomina M, Tapia-Paniagua ST, de Rojas AH, Mira A, Gallego-Parrilla JJ, Díaz TM, Maicas S, Villalobo E, Quindós G, Balboa S, Romalde JL, Aguilar-Pérez C, Tomás A, Linares M, Zaragoza Ó, Gil-Serna J, Ferrer-Espada R, Camacho AI, Vinué L, García-Lara J.

J Microbiol Biol Educ. 2016 Dec 2;17(3):492-494. doi: 10.1128/jmbe.v17i3.1200. eCollection 2016 Dec. No abstract available. Erratum in: J Microbiol Biol Educ. 2018 Jul 31;19(2):.

21.

EPICO 3.0. Management of non-neutropenic patients in medical wards.

Ferrer R, Zaragoza R, Rodríguez AH, Maseda E, Llinares P, Grau S, Álvarez-Lerma F, Quindós G, Salavert M, Huarte R; EPICO Project Group.

Rev Iberoam Micol. 2016 Oct - Dec;33(4):216-223. doi: 10.1016/j.riam.2016.06.003. Epub 2016 Oct 18. Erratum in: Rev Iberoam Micol. 2017 Jan - Mar;34(1):63.

PMID:
27769740
22.

Impact of a multifaceted educational intervention including serious games to improve the management of invasive candidiasis in critically ill patients.

Ferrer R, Zaragoza R, Llinares P, Maseda E, Rodríguez A, Quindós G; EPICO Project Group.

Med Intensiva. 2017 Jan - Feb;41(1):3-11. doi: 10.1016/j.medin.2016.07.003. Epub 2016 Sep 16. English, Spanish.

23.

Vancomycin heteroresistant community associated methicillin-resistant Staphylococcus aureus ST72-SCCmecIVa strain colonizing the nostrils of a five-year-old Spanish girl.

Varona-Barquín A, Iglesias-Losada JJ, Ezpeleta G, Eraso E, Quindós G.

Enferm Infecc Microbiol Clin. 2017 Mar;35(3):148-152. doi: 10.1016/j.eimc.2016.07.015. Epub 2016 Aug 31. English, Spanish.

PMID:
27590877
24.

Detection and characterization of surface microbial contamination in emergency ambulances.

Varona-Barquin A, Ballesteros-Peña S, Lorrio-Palomino S, Ezpeleta G, Zamanillo V, Eraso E, Quindós G.

Am J Infect Control. 2017 Jan 1;45(1):69-71. doi: 10.1016/j.ajic.2016.05.024. Epub 2016 Aug 24.

PMID:
27566871
25.

Fungal diseases: could nanostructured drug delivery systems be a novel paradigm for therapy?

Voltan AR, Quindós G, Alarcón KP, Fusco-Almeida AM, Mendes-Giannini MJ, Chorilli M.

Int J Nanomedicine. 2016 Aug 8;11:3715-30. doi: 10.2147/IJN.S93105. eCollection 2016. Review.

26.

Postantifungal effect of caspofungin against the Candida albicans and Candida parapsilosis clades.

Gil-Alonso S, Jauregizar N, Eraso E, Quindós G.

Diagn Microbiol Infect Dis. 2016 Oct;86(2):172-7. doi: 10.1016/j.diagmicrobio.2016.07.011. Epub 2016 Jul 12.

PMID:
27492134
27.

[Invasive fungal disease by Candida and other yeasts].

Pemán J, Salavert M, Quindós G.

Rev Iberoam Micol. 2016 Jul-Sep;33(3):131-2. doi: 10.1016/j.riam.2016.03.004. Epub 2016 Jun 11. Spanish. No abstract available.

PMID:
27296910
28.

[Current aspects of invasive diseases caused by Candida and other yeast fungi].

Pemán J, Quindós G.

Rev Iberoam Micol. 2016 Jul-Sep;33(3):133-9. doi: 10.1016/j.riam.2015.10.001. Epub 2016 Apr 8. Review. Spanish.

PMID:
27067876
29.

In vitro pharmacodynamic modelling of anidulafungin against Candida spp.

Gil-Alonso S, Jauregizar N, Ortega I, Eraso E, Suárez E, Quindós G.

Int J Antimicrob Agents. 2016 Mar;47(3):178-83. doi: 10.1016/j.ijantimicag.2015.12.011. Epub 2016 Jan 15.

PMID:
26857078
30.

Caries and Candida colonisation in adult patients in Basque Country (Spain).

De-la-Torre J, Marichalar-Mendia X, Varona-Barquin A, Marcos-Arias C, Eraso E, Aguirre-Urizar JM, Quindós G.

Mycoses. 2016 Apr;59(4):234-240. doi: 10.1111/myc.12453. Epub 2016 Jan 12.

PMID:
26756815
31.

Multicenter study of epidemiological cutoff values and detection of resistance in Candida spp. to anidulafungin, caspofungin, and micafungin using the Sensititre YeastOne colorimetric method.

Espinel-Ingroff A, Alvarez-Fernandez M, Cantón E, Carver PL, Chen SC, Eschenauer G, Getsinger DL, Gonzalez GM, Govender NP, Grancini A, Hanson KE, Kidd SE, Klinker K, Kubin CJ, Kus JV, Lockhart SR, Meletiadis J, Morris AJ, Pelaez T, Quindós G, Rodriguez-Iglesias M, Sánchez-Reus F, Shoham S, Wengenack NL, Borrell Solé N, Echeverria J, Esperalba J, Gómez-G de la Pedrosa E, García García I, Linares MJ, Marco F, Merino P, Pemán J, Pérez Del Molino L, Roselló Mayans E, Rubio Calvo C, Ruiz Pérez de Pipaon M, Yagüe G, Garcia-Effron G, Guinea J, Perlin DS, Sanguinetti M, Shields R, Turnidge J.

Antimicrob Agents Chemother. 2015 Nov;59(11):6725-32. doi: 10.1128/AAC.01250-15. Epub 2015 Aug 17.

32.

[Clinical usefulness of triazole derivatives in the management of fungal infections].

Carrillo-Muñoz AJ, Giusiano G, Arechavala A, Tur-Tur C, Eraso E, Jauregizar N, Quindós G, Negroni R.

Rev Esp Quimioter. 2015 Aug;28(4):169-82. Review. Spanish.

33.

Postantifungal Effect of Micafungin against the Species Complexes of Candida albicans and Candida parapsilosis.

Gil-Alonso S, Jauregizar N, Eraso E, Quindós G.

PLoS One. 2015 Jul 13;10(7):e0132730. doi: 10.1371/journal.pone.0132730. eCollection 2015.

34.

In vitro fungicidal activities of anidulafungin, caspofungin, and micafungin against Candida glabrata, Candida bracarensis, and Candida nivariensis evaluated by time-kill studies.

Gil-Alonso S, Jauregizar N, Cantón E, Eraso E, Quindós G.

Antimicrob Agents Chemother. 2015;59(6):3615-8. doi: 10.1128/AAC.04474-14. Epub 2015 Mar 23.

35.

Comparison of the in vitro activity of echinocandins against Candida albicans, Candida dubliniensis, and Candida africana by time-kill curves.

Gil-Alonso S, Jauregizar N, Cantón E, Eraso E, Quindós G.

Diagn Microbiol Infect Dis. 2015 May;82(1):57-61. doi: 10.1016/j.diagmicrobio.2015.01.010. Epub 2015 Feb 2.

PMID:
25703894
36.

[State of the art in invasive diseases by filamentous fungi].

Pemán J, Quindós G.

Rev Iberoam Micol. 2014 Oct-Dec;31(4):213-8. doi: 10.1016/j.riam.2014.07.003. Epub 2014 Sep 30. Review. Spanish.

PMID:
25449676
37.

[Invasive infection diseases by filamentous fungi].

Pemán J, Salavert M, Quindós G.

Rev Iberoam Micol. 2014 Oct-Dec;31(4):211-2. doi: 10.1016/j.riam.2014.07.002. Epub 2014 Sep 8. Spanish. No abstract available.

PMID:
25434345
38.

Combination antifungal therapy: a strategy for the management of invasive fungal infections.

Carrillo-Muñoz AJ, Finquelievich J, Tur-Tur C, Eraso E, Jauregizar N, Quindós G, Giusiano G.

Rev Esp Quimioter. 2014 Sep;27(3):141-58. Review. No abstract available.

39.

Candida antigens and immune responses: implications for a vaccine.

Moragues MD, Rementeria A, Sevilla MJ, Eraso E, Quindos G.

Expert Rev Vaccines. 2014 Aug;13(8):1001-12. doi: 10.1586/14760584.2014.932253. Epub 2014 Jun 24. Review.

PMID:
24957934
40.

Epidemiology of candidaemia and invasive candidiasis. A changing face.

Quindós G.

Rev Iberoam Micol. 2014 Jan-Mar;31(1):42-8. doi: 10.1016/j.riam.2013.10.001. Epub 2013 Nov 19. Review.

PMID:
24270071
41.

[Presence of Candida in recurrent aphthous stomatitis].

Eguia A, Marcos-Arias C, Eraso E, Quindós G, Aguirre JM.

Rev Iberoam Micol. 2013 Oct-Dec;30(4):271-2. doi: 10.1016/j.riam.2013.03.003. Epub 2013 Apr 11. Spanish. No abstract available.

PMID:
23583264
42.

Sertaconazole: an antifungal agent for the topical treatment of superficial candidiasis.

Carrillo-Muñoz AJ, Tur-Tur C, Giusiano G, Marcos-Arias C, Eraso E, Jauregizar N, Quindós G.

Expert Rev Anti Infect Ther. 2013 Apr;11(4):347-58. doi: 10.1586/eri.13.17. Review.

PMID:
23566144
43.

Accurate identification of Candida parapsilosis (sensu lato) by use of mitochondrial DNA and real-time PCR.

Souza AC, Ferreira RC, Gonçalves SS, Quindós G, Eraso E, Bizerra FC, Briones MR, Colombo AL.

J Clin Microbiol. 2012 Jul;50(7):2310-4. doi: 10.1128/JCM.00303-12. Epub 2012 Apr 25.

44.

Validation of the PCR-dHPLC method for rapid identification of Candida glabrata phylogenetically related species in different biological matrices.

Telleria O, Ezpeleta G, Herrero O, Miranda-Zapico I, Quindós G, Cisterna R.

J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Apr 15;893-894:150-6. doi: 10.1016/j.jchromb.2012.03.007. Epub 2012 Mar 9.

PMID:
22456535
45.

Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey.

Pemán J, Cantón E, Quindós G, Eraso E, Alcoba J, Guinea J, Merino P, Ruiz-Pérez-de-Pipaon MT, Pérez-del-Molino L, Linares-Sicilia MJ, Marco F, García J, Roselló EM, Gómez-G-de-la-Pedrosa E, Borrell N, Porras A, Yagüe G; FUNGEMYCA Study Group.

J Antimicrob Chemother. 2012 May;67(5):1181-7. doi: 10.1093/jac/dks019. Epub 2012 Feb 20.

PMID:
22351683
46.

[Invasive fungal disease: conventional or molecular mycological diagnosis?].

Quindós G, Eraso E, López-Soria LM, Ezpeleta G.

Enferm Infecc Microbiol Clin. 2012 Nov;30(9):560-71. doi: 10.1016/j.eimc.2011.10.018. Epub 2011 Dec 27. Review. Spanish.

PMID:
22206948
47.

In vitro activities of natural products against oral Candida isolates from denture wearers.

Marcos-Arias C, Eraso E, Madariaga L, Quindós G.

BMC Complement Altern Med. 2011 Nov 26;11:119. doi: 10.1186/1472-6882-11-119.

48.

Prospective multicenter study of the epidemiology, molecular identification, and antifungal susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis isolated from patients with candidemia.

Cantón E, Pemán J, Quindós G, Eraso E, Miranda-Zapico I, Álvarez M, Merino P, Campos-Herrero I, Marco F, de la Pedrosa EG, Yagüe G, Guna R, Rubio C, Miranda C, Pazos C, Velasco D; FUNGEMYCA Study Group.

Antimicrob Agents Chemother. 2011 Dec;55(12):5590-6. doi: 10.1128/AAC.00466-11. Epub 2011 Sep 19.

49.

Variation in biofilm formation among blood and oral isolates of Candida albicans and Candida dubliniensis.

Villar-Vidal M, Marcos-Arias C, Eraso E, Quindós G.

Enferm Infecc Microbiol Clin. 2011 Nov;29(9):660-5. doi: 10.1016/j.eimc.2011.06.009. Epub 2011 Sep 6.

PMID:
21899928
50.

Anidulafungin in treatment of experimental invasive infection by Candida parapsilosis: in vitro activity, (1-->3)-beta-D-glucan and mannan serum levels, histopathological findings, and in vivo efficacy.

Salas V, Pastor FJ, Calvo E, Mayayo E, Quindós G, Carrillo AJ, Guarro J.

Antimicrob Agents Chemother. 2011 Nov;55(11):4985-9. doi: 10.1128/AAC.00500-11. Epub 2011 Aug 15.

Supplemental Content

Loading ...
Support Center